ADVERTISEMENT

National event release for Force of Destiny

Following the outstanding reception at the opening night of the Melbourne International Film Festival, CinemaPlus and Illumination Films have crafted a unique national event release for Paul Cox’s Force of Destiny.

The schedule includes major film festivals, a limited edition cinema program and a series of screenings featuring special guests and speakers.

In opening MIFF, Paul Cox said “The proof of our lives is the love we leave behind. If I had to live life again I would be crazier than I have been. I would laugh more and cry less and would be more aware of the fact that life must be an act of love whatever the consequences. Force of Destiny is an outpouring of my love.”

Robert Connolly said “The success of The Turning’s event screening approach is something CinemaPlus is further developing with the release of Force of Destiny. We are thrilled and excited to be presenting this very special film in a very special way.”

In the first wave of event announcements, the film will screen as opening night of the Darwin International Film Festival in September and the Albury Border Mail Film Festival in August, followed by Cinéfest Oz and Brisbane Asia Pacific Film Festival special screenings.

Many screenings will be presented with a Q&A or special introduction with Cox, actors David Wenham, Hannah Fredericksen, Jacqueline McKenzie, Terry Norris and Julia Blake, producers Maggie Miles and Mark Patterson, transplant recipients Derryn Hinch and Paulie Stewart and other creatives including sculptor Trefor Prest who created the work for the film.

The will provide cinema audiences with contextual information on director Cox and the personal experiences he has poured into this film. The filmmakers have collaborated with DonateLife on a unique collection of filmed Micro Stories, portraits of people impacted by Organ Donation, and with the Cancer Council on an cinema program giving insight into the making of the film and important information for people living with cancer.